Alignment Healthcare (ALHC) slides as investors digest index addition and leadership shake-up

Alignment Healthcare, Inc. (ALHC) is down 9.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The catalyst for today’s drop is not fully clear, but the timing suggests a “sell-the-news” reaction after recent corporate updates, including ALHC’s addition to the S&P SmallCap 600 and a set of leadership changes. After index-related buying and headline-driven interest, the stock may have seen profit-taking and rebalancing-related volatility.

Details:

ALHC closed May 14, 2026 down about 9.36%, reflecting a sharp one-day reversal after a volatile stretch in recent weeks.

ALHC was added to the S&P SmallCap 600 effective prior to the opening of trading on May 14, which can sometimes drive short-term inflows ahead of inclusion and then fade afterward.

In a May 12 company announcement, founder and CEO John Kao also took on the chairman role, the prior chairman moved into a vice chair position, and the company added senior operating leadership (including a new COO and MSO president).

In late April, Alignment reported strong first-quarter 2026 results with rapid revenue and membership growth and raised the midpoint of its full-year outlook, setting a higher expectation bar that can amplify post-earnings swings.

Sources:

Stock Analysis, GlobeNewswire, PR Newswire

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ALHC Insider Trading Activity

$ALHC insiders have traded $ALHC stock on the open market 57 times in the past 6 months. Of those trades, 0 have been purchases and 57 have been sales.

Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:

ATLANTIC, L.P. GENERAL sold 11,119,494 shares for an estimated $206,489,003
ATLANTIC (ALN HLTH), L.P. GENERAL sold 11,119,494 shares for an estimated $206,489,003
JOHN E KAO (Chief Executive Officer) has made 0 purchases and 18 sales selling 2,411,593 shares for an estimated $46,201,221.
DAWN CHRISTINE MARONEY (President) has made 0 purchases and 14 sales selling 926,084 shares for an estimated $18,366,502.
CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 6 sales selling 89,642 shares for an estimated $1,665,606.
ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 5 sales selling 84,870 shares for an estimated $1,575,263.
ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 66,958 shares for an estimated $1,273,939.
HYONG KIM (Chief Medical Officer) has made 0 purchases and 4 sales selling 47,604 shares for an estimated $918,603.
SEBASTIAN BURZACCHI (COO - Mgmt Services Org) has made 0 purchases and 2 sales selling 27,946 shares for an estimated $516,427.
JOSEPH S KONOWIECKI sold 25,000 shares for an estimated $475,000
JAMES M HEAD (Chief Financial Officer) sold 11,100 shares for an estimated $233,987

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive ALHC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ALHC Hedge Fund Activity

We have seen 165 institutional investors add shares of $ALHC stock to their portfolio, and 123 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GENERAL ATLANTIC, L.P. removed 11,119,494 shares (-45.8%) from their portfolio in Q4 2025, for an estimated $219,610,006
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 10,874,567 shares (-86.5%) from their portfolio in Q4 2025, for an estimated $214,772,698
FMR LLC added 6,574,721 shares (+81.4%) to their portfolio in Q4 2025, for an estimated $129,850,739
CAPITAL RESEARCH GLOBAL INVESTORS added 3,593,576 shares (+inf%) to their portfolio in Q1 2026, for an estimated $63,318,809
WELLINGTON MANAGEMENT GROUP LLP added 2,981,166 shares (+26.9%) to their portfolio in Q4 2025, for an estimated $58,878,028
MILLENNIUM MANAGEMENT LLC removed 2,924,624 shares (-53.3%) from their portfolio in Q4 2025, for an estimated $57,761,324
BANK OF NEW YORK MELLON CORP added 2,316,777 shares (+232.5%) to their portfolio in Q1 2026, for an estimated $40,821,610

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ALHC Analyst Ratings

Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 01/06/2026
JP Morgan issued a "Overweight" rating on 11/24/2025

To track analyst ratings and price targets for $ALHC, check out Quiver Quantitative's $ALHC forecast page.

$ALHC Price Targets

Multiple analysts have issued price targets for $ALHC recently. We have seen 7 analysts offer price targets for $ALHC in the last 6 months, with a median target of $23.0.

Here are some recent targets:

Andrew Mok from Barclays set a target price of $19.0 on 05/01/2026
Jonathan Yong from UBS set a target price of $22.0 on 05/01/2026
John Stansel from JP Morgan set a target price of $26.0 on 02/05/2026
Ryan Langston from TD Cowen set a target price of $25.0 on 01/16/2026
Jessica Tassan from Piper Sandler set a target price of $30.0 on 01/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.